Activation of the cannabinoid 2 receptor may be a potential treatment option for insulin resistance and obesity-related diabetes.
This according to new research at the Institute of Biomedical Engineering at the Chinese Academy of Medical Science, the was study was first published in the Journal of Cellular Physiology and Biochemistry.
The endocannabinoid signalling (ECS) system has been known to regulate glucose homeostasis. Previous studies have suggested that the cannabinoid 2 (CB2) receptor may play a regulatory role on insulin secretion, immune modulation and insulin resistance. Given that diabetes and insulin resistance are attributable to elevated inflammatory tone, we investigated the role of CB2 receptor on glucose tolerance and insulin sensitivity in high-fat diet (HFD)/streptozotocin (STZ)-induced mice.
In other words smoking dope may actually be good for you.
The Canadian task force on Cannabis Legalization and Regulation has released “A Framework for the Legalization and Regulation of Cannabis in Canada.”
It only took five months, which by government standards is light speed. They covered everything from advertising and taxation to growing marijuana and processing concentrates.
Here’s the index:
Table of Contents
Chapter 1: Introduction
The Canadian context
A global perspective
Setting the frame
Public policy objectives
Chapter 2: Minimizing Harms of Use
Introduction: a public health approach
Promotion, advertising and marketing restrictions
Cannabis-based edibles and other products
Tax and price
Prevention and treatment
Chapter 3: Establishing a Safe and Responsible Supply Chain
Chapter 4: Enforcing Public Safety and Protection
Place of use
Chapter 5: Medical Access
One system or two?
Evidence and research
Chapter 6: Implementation
Annex 1: Biographies of Task Force on Cannabis Legalization and Regulation Members
Annex 2: Terms of Reference
Annex 3: Acknowledgements
Annex 4: Discussion Paper ‘Toward the Legalization, Regulation and Restriction of Access to Marijuana’
Annex 5: Executive Summary: Analysis of consultation input submitted to the Task Force on Cannabis Legalization and Regulation
You read that right. It really is 6 chapters and 5 annexes.
Talk about dotting your Is and crossing your Ts.
Well the DEA has finally started easing restrictions on testing marijuana as a treatment for PTSD. It’s only taken one doctor 5 years to wade through the paperwork / bureaucratic nightmare.
Dr. Sisley, a psychiatrist and former clinical assistant professor at the University of Arizona College of Medicine, has been fighting to carry out the study since 2011, when it was first approved by the U.S. Food and Drug Administration.
First: The federal government categorizes marijuana as a Schedule 1 drug, the most restrictive of five groups.
Second: The only approved cannabis source is the University of Mississippi.
Next: Researchers like Dr. Sisley must apply to the Food and Drug Administration, the Drug Enforcement Administration and the National Institute on Drug Abuse
And to top it off participants will need to be veterans diagnosed with PTSD who have found their condition resistant to conventional treatments. (40 in Phoenix and 40 in Baltimore)
My hat’s off to the good doctor because you really have to be dedicated jump through that many hoops.
The rules for edibles in Colorado have changed.
Beginning Oct. 1:
All new medical and retail marijuana packaging must feature the new universal symbol
on the front. Medical and retail marijuana will have similar, but different symbols.
Examples of the symbols can be found here.
Packaging must include the following statement directly below the symbol: “Contains Marijuana. Keep out of the
reach of children.”
Marijuana infused product manufacturers must comply with the new universal symbol rules by Oct, 1.
By Dec, 1, retail stores and medical centers may only sell marijuana marked with the universal symbol.
Retail marijuana specific universal symbol rules:
Every single standardized serving (a serving consists of 10 mg of THC) of an edible retail marijuana product must be individually marked, stamped or imprinted with the new universal symbol.
When impractical to mark an edible retail marijuana product with the universal symbol, as in the case of bulk goods and powders, these must be packaged in a single serving, child-resistant container.
In an edible retail marijuana product that contains multiple servings, each single standardized serving must be marked, stamped or imprinted with the universal symbol.
Medical marijuana specific universal symbol rules:
Edible medical marijuana infused products must be marked, stamped
or imprinted with the universal symbol.
Medical marijuana infused product manufacturers may choose to determine standard portions.
Each portion must be marked, stamped or imprinted with the universal symbol.
Other important marijuana packaging rules going into effect Oct, 1:
The words “candy” or “candies” cannot appear on marijuana or marijuana packaging,
unless part of the marijuana establishment’s name.
Each container of medical and retail marijuana must be labeled with necessary and relevant information for consumers, including a potency statement and a contaminant testing statement.
The information must be easily accessible to consumers, clear and noticeable. Health and physical benefit claims cannot be included on labels
What all this means is that marijuana edibles should be safer, and if there is very much leftover inventory it could turn out to be a very happy Thanksgiving.
According to the Institute of Governmental Studies at the University of California in Berkley, the vast majority(63.8%) of voters in California plan to vote “Yes” on Proposition 64 this November.
The proposition would legalize recreational cannabis and allow anyone over 21 to possess up to 1oz of marijuana and grow as many as 6 plants.
The poll questioned 3000 registered voters in the state from June 29 to July 18, 2016. With support being highest among African Americans at 71.9% and lowest among Asian voters at 57.7%.